Richard L Md Lindstrom is Director of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 162,704 shares of OCUL, which is worth approximately $1.43 Million. The most recent transaction as insider was on Jul 24, 2024, when has been sold 12,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K
0% 3M change
35.13% 12M change
Total Value Held $1.43 Million

RICHARD L MD LINDSTROM Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 24 2024
BUY
Grant, award, or other acquisition
-
12,000 Added 6.87%
162,704 Common Stock
Feb 27 2024
BUY
Exercise of conversion of derivative security
$266,657 $8.8 p/Share
30,302 Added 16.74%
150,704 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
12,000 Added 9.06%
120,402 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
8,933 Added 7.61%
108,402 Common Stock
May 12 2022
BUY
Exercise of conversion of derivative security
$11,552 $1.22 p/Share
9,469 Added 8.69%
99,469 Common Stock
May 20 2021
SELL
Open market or private sale
$143,000 $14.3 p/Share
10,000 Reduced 10.0%
90,000 Common Stock

Also insider at

HROW
HARROW HEALTH, INC. Healthcare
LNSR
LENSAR, Inc. Healthcare
RLM

Richard L Md Lindstrom

Director
Orlando, FL

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Track Activities on OCUL